Johnson & Johnson (JNJ) Inventory Average (2009 - 2026)
Johnson & Johnson's (JNJ) quarterly Inventory Average came in at $14.9 billion in Q2 2026, up 14.02% year-over-year from $13.0 billion in Q2 2025, and up 3.31% quarter-over-quarter from $14.4 billion in Q1 2026.
Analysis
Johnson & Johnson (JNJ) Inventory Average (2009 - 2026) Analysis & Trends
Johnson & Johnson has disclosed Inventory Average across 18 years of filings, most recently posting $14.9 billion for Q2 2026.
- In Q2 2026, Inventory Average rose 14.02% year-over-year to $14.9 billion; the TTM figure through Jun 2026 stood at $14.9 billion (up 14.02% YoY), while the FY2025 annual figure was $13.3 billion, up 12.74% from the prior year.
- Inventory Average came in at $14.9 billion for Q2 2026 at Johnson & Johnson, up from $14.4 billion in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $14.9 billion in Q2 2026 to a low of $10.4 billion in Q1 2022.
- Average Inventory Average over 5 years is $12.3 billion, with a median of $12.0 billion recorded in 2023.
- Year-over-year, Inventory Average dropped 8.35% in 2024 and climbed 14.62% in 2026.
- Over 5 years, Inventory Average stood at $11.6 billion in 2022, then dropped by 3.17% to $11.2 billion in 2023, then increased by 11.92% to $12.5 billion in 2024, then increased by 13.14% to $14.2 billion in 2025, then rose by 4.91% to $14.9 billion in 2026.
- Per Business Quant data, the three most recent Inventory Average figures were $14.9 billion in Q2 2026, $14.4 billion in Q1 2026, and $14.2 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 14.86 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 5.09 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 6.34 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 6.25 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 10.31 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 114.08 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 186.05 Mn |
| 10 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 84.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 14.86 Bn |
| Mar 29, 2026 | 14.39 Bn |
| Dec 28, 2025 | 14.17 Bn |
| Sep 28, 2025 | 13.78 Bn |
| Jun 29, 2025 | 13.04 Bn |
| Mar 30, 2025 | 12.55 Bn |
| Dec 29, 2024 | 12.52 Bn |
| Sep 29, 2024 | 12.39 Bn |
| Jun 30, 2024 | 11.78 Bn |
| Mar 31, 2024 | 11.28 Bn |
| Dec 31, 2023 | 11.19 Bn |
| Oct 1, 2023 | 12.04 Bn |
| Jul 2, 2023 | 12.85 Bn |
| Apr 2, 2023 | 11.54 Bn |
| Jan 1, 2023 | 10.97 Bn |
| Oct 2, 2022 | 11.56 Bn |
| Jul 3, 2022 | 11.21 Bn |
| Apr 3, 2022 | 10.69 Bn |
| Jan 2, 2022 | 10.39 Bn |
| Oct 3, 2021 | 10.24 Bn |